Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interactions Between Natural Products and Tamoxifen in Breast Cancer: A Comprehensive Literature Review
Christine Yen, Fan Zhao, Zhichao Yu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 20

Showing 20 citing articles:

Natural products reverse cancer multidrug resistance
Jiayu Zou, Qilei Chen, Xiao-Ci Luo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 14
A comprehensive review on Ellagic acid in breast cancer treatment: From cellular effects to molecular mechanisms of action
Maryam Golmohammadi, Mohammad Yasin Zamanian, Sahbanathul Missiriya Jalal, et al.
Food Science & Nutrition (2023) Vol. 11, Iss. 12, pp. 7458-7468
Open Access | Times Cited: 14
Systems Theory-Driven Framework for AI Integration into the Holistic Material Basis Research of Traditional Chinese Medicine
Jingqi Zeng, Xiao‐Bin Jia
Engineering (2024) Vol. 40, pp. 28-50
Open Access | Times Cited: 5
Epigallocatechin-3-gallate therapeutic potential in human diseases: molecular mechanisms and clinical studies
Manzar Alam, Mehak Gulzar, Salman Akhtar, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 5
Mechanisms of Traditional Chinese medicine/natural medicine in HR-positive Breast Cancer: A comprehensive Literature Review
Qinghong Yu, Chuchu Xu, Jiaqing Song, et al.
Journal of Ethnopharmacology (2023) Vol. 319, pp. 117322-117322
Closed Access | Times Cited: 11
Lactic Acid Bacteria-Derived Postbiotics as Adjunctive Agents in Breast Cancer Treatment to Boost the Antineoplastic Effect of a Conventional Therapeutic Comprising Tamoxifen and a New Drug Candidate: An Aziridine–Hydrazide Hydrazone Derivative
J. WASIAK, Pola Głowacka, Agnieszka Pudlarz, et al.
Molecules (2024) Vol. 29, Iss. 10, pp. 2292-2292
Open Access | Times Cited: 4
SARCOPENIA AND GASTROINTESTINAL CANCER: NUTRITIONAL APPROACH FOCUSING ON CURCUMIN SUPPLEMENTATION
Patrícia Noronha de Almeida, Katia Barão, Nora Manoukian FORONES
Arquivos de Gastroenterologia (2025) Vol. 62
Open Access
An Update on Tamoxifen and the Chemo-Preventive Potential of Vitamin E in Breast Cancer Management
Farid Khallouki, Lhoussain Hajji, Somayya Saber, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 5, pp. 754-754
Open Access | Times Cited: 7
Combination of tamoxifen and D-limonene enhances therapeutic efficacy in breast cancer cells
Deepa Mandal, Bikash Ranjan Sahu, Tithi Parija
Medical Oncology (2023) Vol. 40, Iss. 8
Closed Access | Times Cited: 4
Enhancing Traditional Chinese Medicine healthcare system in Taiwan post-COVID-19 pandemic: A strategic focus on specialization
Shun‐Ku Lin, Jung‐Nien Lai
Journal of the Formosan Medical Association (2024)
Open Access | Times Cited: 1
Synthesis and anti-proliferative activity of dehydroabietinol derivatives bearing a triazole moiety
Mingjun Zhu, Jinchuan Sun, Yaju Wu, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 4, pp. 680-691
Closed Access | Times Cited: 2
Molecular Action of Tamoxifen in the Ovaries of Rats with Mammary Neoplasia
Anna Nynca, Sylwia Świgońska, Tomasz Molcan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15767-15767
Open Access | Times Cited: 2
Synergistic effect of Erythrina variegata L. and tamoxifen against the growth of breast cancer cells
Van Thi Hong Tran, Thi Vân Hoang, Viet Hung Lai, et al.
Tạp chí Nghiên cứu Dược và Thông tin Thuốc (2024)
Open Access
Influence of CYP2D6 and its polymorphic forms on the metabolism of tamoxifen in therapy of luminal forms of breast cancer
P. O. Yurchenko, В. М. Шкарупа, O. Y. Kakarkin, et al.
Reports of Vinnytsia National Medical University (2024) Vol. 28, Iss. 1, pp. 156-160
Open Access
Citrus polymethoxyflavones degrade estrogen receptor-alpha (ERα) and combine with tamoxifen for the treatment of estrogen receptor-positive breast cancer
Yiyu Wang, Meng Sun, Zhong He, et al.
Heliyon (2024) Vol. 10, Iss. 12, pp. e33104-e33104
Open Access
Harnessing the immunomodulatory potential of natural products in precision medicine—a comprehensive review
Maya G. Pillai, A. Helen
(2024), pp. 339-360
Closed Access
Unleashing the potential of Genistein and its derivatives as effective therapeutic agents for breast cancer treatment
Eskandar Qaed, Wu Liu, Marwan Almoiliqy, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access
Does Angelica Sinensis (Dang-qui) Increase the Risk of Breast Cancer? A Systematic Review
Yingling Chen, Mark C. Hou, Yafen Hsu
Future Integrative Medicine (2023) Vol. 2, Iss. 2, pp. 99-106
Open Access | Times Cited: 1
Research Progress of Natural Drugs for Breast Cancer in the Past 30 Years Based on Bibliometric and Knowledge Graph Analysis
Le Gao, Tian Yang, Ziru Xue, et al.
(2023)
Open Access | Times Cited: 1
Tackling heterogeneity in treatment-resistant breast cancer using a broad-spectrum therapeutic approach
Leroy Lowe, J. William LaValley, Dean W. Felsher
Cancer Drug Resistance (2022) Vol. 5, pp. 917-25
Open Access | Times Cited: 2
Page 1

Scroll to top